Grifols GRFS
NASDAQ GRFS
$8.62 -0.14 (-1.60%)
As of: Nov 11, 2026 · 10:06 AM EST

Grifols (GRFS) Current Leases (2015 - 2016)

Updated

Grifols (GRFS) recorded Current Leases of $103.37 million in the quarter ended Mar 31, 2016, up 18.9% from the prior quarter.

Analysis

Grifols (GRFS) Current Leases (2015 - 2016) Analysis & Trends

As of Dec 31, 2015, Grifols reported Current Leases of $86.96 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Grifols 5.96 Bn 5.04 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 103.37 Mn
Dec 31, 2015 86.96 Mn
API Access

Grifols Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=GRFS&period=max&api_key=YOUR_API_KEY